Put Options

9 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$11.7 - $28.46 $5.85 Million - $14.2 Million
-499,900 Reduced 99.98%
100 $1,000
Q2 2024

Aug 14, 2024

BUY
$25.5 - $31.51 $9.64 Million - $11.9 Million
378,000 Added 309.84%
500,000 $14.3 Million
Q1 2024

May 15, 2024

BUY
$27.7 - $35.48 $3.38 Million - $4.33 Million
122,000 New
122,000 $3.56 Million
Q2 2022

Aug 15, 2022

SELL
$51.49 - $81.64 $7.72 Million - $12.2 Million
-150,000 Closed
0 $0
Q1 2022

May 13, 2022

BUY
$60.03 - $76.49 $9 Million - $11.5 Million
150,000 New
150,000 $11.4 Million
Q1 2021

May 17, 2021

SELL
$59.31 - $78.82 $1.48 Million - $1.97 Million
-25,000 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$51.97 - $63.0 $1.3 Million - $1.58 Million
25,000 New
25,000 $1.5 Million
Q2 2020

Aug 14, 2020

SELL
$30.8 - $52.47 $1.85 Million - $3.15 Million
-60,000 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$28.4 - $50.7 $1.7 Million - $3.04 Million
60,000 New
60,000 $2.01 Million

Others Institutions Holding PCRX

About Pacira BioSciences, Inc.


  • Ticker PCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 45,824,200
  • Market Cap $870M
  • Description
  • Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...
More about PCRX
Track This Portfolio

Track Caption Management, LLC Portfolio

Follow Caption Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.